Stryker EBITDA 2010-2024 | SYK

Stryker annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Stryker EBITDA for the quarter ending December 31, 2024 was $845M, a 43.93% decline year-over-year.
  • Stryker EBITDA for the twelve months ending December 31, 2024 was $4.739B, a 3.6% decline year-over-year.
  • Stryker 2024 annual EBITDA was $4.739B, a 3.6% decline from 2023.
  • Stryker 2023 annual EBITDA was $4.916B, a 28.05% increase from 2022.
  • Stryker 2022 annual EBITDA was $3.839B, a 7.41% increase from 2021.
Stryker Annual EBITDA
(Millions of US $)
2024 $4,739
2023 $4,916
2022 $3,839
2021 $3,574
2020 $3,035
2019 $3,491
2018 $3,260
2017 $2,939
2016 $2,721
2015 $2,258
2014 $1,624
2013 $1,563
2012 $2,018
2011 $1,846
2010 $1,916
2009 $1,979
Stryker Quarterly EBITDA
(Millions of US $)
2024-12-31 $845
2024-09-30 $1,353
2024-06-30 $1,309
2024-03-31 $1,232
2023-12-31 $1,507
2023-09-30 $1,193
2023-06-30 $1,224
2023-03-31 $992
2022-12-31 $1,067
2022-09-30 $1,058
2022-06-30 $1,025
2022-03-31 $689
2021-12-31 $1,057
2021-09-30 $809
2021-06-30 $973
2021-03-31 $735
2020-12-31 $972
2020-09-30 $1,057
2020-06-30 $173
2020-03-31 $833
2019-12-31 $1,139
2019-09-30 $822
2019-06-30 $812
2019-03-31 $718
2018-12-31 $874
2018-09-30 $761
2018-06-30 $858
2018-03-31 $767
2017-12-31 $883
2017-09-30 $688
2017-06-30 $662
2017-03-31 $706
2016-12-31 $821
2016-09-30 $634
2016-06-30 $645
2016-03-31 $621
2015-12-31 $756
2015-09-30 $479
2015-06-30 $523
2015-03-31 $500
2014-12-31 $564
2014-09-30 $547
2014-06-30 $291
2014-03-31 $222
2013-12-31 $512
2013-09-30 $226
2013-06-30 $401
2013-03-31 $424
2012-12-31 $532
2012-09-30 $488
2012-06-30 $452
2012-03-31 $546
2011-12-31 $219
2011-09-30 $568
2011-06-30 $521
2011-03-31 $538
2010-12-31 $252
2010-09-30 $572
2010-06-30 $547
2010-03-31 $546
2009-12-31 $618
2009-09-30 $500
2009-06-30 $390
2009-03-31 $471
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $148.126B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.641B 27.61
Boston Scientific (BSX) United States $152.191B 38.10
EssilorLuxottica (ESLOY) France $127.448B 0.00
Medtronic (MDT) Ireland $110.055B 16.07
Lonza Group Ag (LZAGY) Switzerland $49.786B 0.00
Haleon (HLN) United Kingdom $48.281B 27.46
ResMed (RMD) United States $36.314B 27.27
GE HealthCare Technologies (GEHC) United States $33.934B 16.11
Agilent Technologies (A) United States $32.944B 21.76
Terumo (TRUMY) Japan $28.086B 0.00
Koninklijke Philips (PHG) Netherlands $23.536B 16.92
Insulet (PODD) United States $22.286B 87.48
Zimmer Biomet Holdings (ZBH) United States $19.433B 12.48
Baxter (BAX) United States $16.360B 12.22
Smith & Nephew SNATS (SNN) United Kingdom $12.456B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.030B 0.00
Bio-Rad Laboratories (BIO) United States $7.190B 24.31
Lantheus Holdings (LNTH) United States $5.502B 13.88
Prestige Consumer Healthcare (PBH) United States $4.350B 19.43
Perrigo (PRGO) Ireland $3.711B 9.40
ICU Medical (ICUI) United States $3.552B 26.20
Haemonetics (HAE) United States $3.528B 15.37
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.144B 26.13
QuidelOrtho (QDEL) United States $2.531B 17.41
GN Store Nord (GNNDY) Denmark $2.188B 18.12
LeMaitre Vascular (LMAT) United States $1.863B 41.65
AtriCure (ATRC) United States $1.575B 0.00
Neogen (NEOG) United States $1.411B 18.06
AdaptHealth (AHCO) United States $1.229B 12.48
Kestra Medical Technologies (KMTS) United States $1.211B 0.00
Green Thumb Industries (GTBIF) United States $1.152B 25.91
BioLife Solutions (BLFS) United States $1.135B 0.00
InMode (INMD) Israel $1.043B 9.55
Phibro Animal Health (PAHC) United States $0.992B 12.69
Evolus (EOLS) United States $0.643B 0.00
CeriBell (CBLL) United States $0.620B 0.00
Owens & Minor (OMI) United States $0.552B 4.58
Curaleaf Holdings (CURLF) Canada $0.545B 0.00
Valneva SE (VALN) France $0.539B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.539B 0.00
Tilray Brands (TLRY) Canada $0.462B 0.00
Surmodics (SRDX) United States $0.387B 0.00
Cresco Labs (CRLBF) United States $0.357B 0.00
SNDL (SNDL) Canada $0.347B 0.00
Capricor Therapeutics (CAPR) United States $0.325B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
VAREX IMAGING (VREX) United States $0.310B 11.39
Sanara MedTech (SMTI) United States $0.305B 0.00
Aurora Cannabis (ACB) Canada $0.284B 50.60
Canopy Growth (CGC) Canada $0.268B 0.00
Sanuwave Health (SNWV) United States $0.261B 0.00
Cerus (CERS) United States $0.258B 0.00
Viemed Healthcare (VMD) United States $0.257B 21.70
ZimVie (ZIMV) United States $0.248B 11.28
Verano Holdings (VRNOF) United States $0.248B 0.00
Quanterix (QTRX) United States $0.222B 0.00
Omeros (OMER) United States $0.221B 0.00
Biote (BTMD) United States $0.218B 6.14
OraSure Technologies (OSUR) United States $0.200B 0.00
High Tide (HITI) Canada $0.192B 0.00
Utah Medical Products (UTMD) United States $0.177B 14.29
Organigram Global (OGI) Canada $0.171B 0.00
Brainsway (BWAY) Israel $0.167B 51.94
TriSalus Life Sciences (TLSI) United States $0.165B 0.00
FitLife Brands (FTLF) United States $0.145B 17.82
Jin Medical (ZJYL) China $0.141B 0.00
Exagen (XGN) United States $0.123B 0.00
TerrAscend (TSNDF) Canada $0.107B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Quipt Home Medical (QIPT) United States $0.092B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Agape ATP (ATPC) $0.083B 0.00
Fonar (FONR) United States $0.077B 10.76
Veru (VERU) United States $0.076B 0.00
Jushi Holdings (JUSHF) United States $0.070B 0.00
InterCure (INCR) Israel $0.069B 0.00
Zynex (ZYXI) United States $0.065B 0.00
United Health Products (UEEC) United States $0.061B 0.00
Cytosorbents (CTSO) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Apyx Medical (APYX) United States $0.042B 0.00
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.038B 13.10
Safety Shot (SHOT) United States $0.037B 0.00
Rockwell Medical (RMTI) United States $0.036B 0.00
Nephros (NEPH) United States $0.022B 0.00
INLIF (INLF) $0.019B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00